Side-Effect Management

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

Distress: Measuring its relation to cancer diagnosis and treatment

Rosemarie A. Tucci, RN, MSN January 26, 2012

Nurses should assess cancer patients frequently and intervene promptly throughout the treatment course.
 

Impact of CYP3A4 pathway

January 26, 2012

How does the CYP3A4 pathway impact metabolism of the new oral targeted agents in oncology?
 

Bevacizumab Efficacious for HER2-Negative Breast Cancer

January 25, 2012

Two studies show improved pathologic complete response with addition of bevacizumab.
 

Therapeutic vaccine for brain cancer being studied

January 24, 2012

A vaccine for people newly diagnosed with glioblastoma multiforme—the most aggressive and highest-grade malignant glioma—is being tested at 20 sites nationwide in a phase II trial.
 

Many parents tell kids about breast cancer gene test results

January 20, 2012

Parents are more likely than not to tell their sons and daughters younger than 25 years whether or not the parent carries inheritable mutations in BRCA1 or BRCA2 genes.
 

Proton therapy effective against prostate cancer

January 19, 2012

Two studies published in International Journal of Radiation Oncology*Biology*Physics indicate that proton therapy is a useful treatment for prostate cancer.
 

Quality of life after esophagectomy on par with general population for most

January 18, 2012

After surgical treatment of esophageal cancer, quality of life stays the same or gets better for many people, research indicates. Those who show early signs of impaired QoL should be identified and helped.
 
ONA Newsletters
Sign up today for one of our free newsletters:
  • Issue Preview
  • Latest CE
  • Reflections
  • Editor's choice
  • New on the Web

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions